Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

NCT05932511 EARLY_PHASE1 UNKNOWN

Randomized comparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment of biopsy proven squamous cell carcinomas of the skin in otherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.

Details

Lead sponsor	Center for Biomedical Research, Inc.
Phase	EARLY_PHASE1
Status	UNKNOWN
Enrolment	15
Start date	Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Squamous Cell Cancer
• Squamous Cell Carcinoma
• Skin Cancer
• Non-melanoma Skin Cancer

Interventions

• 30% ascorbic acid in DMSO

Countries

United States